Zimbabwe has declined a significant American healthcare agreement valued at $367m (272 million pounds) spanning five years because of Washington's demand for sensitive data.
This move was revealed following a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
An official representative has since clarified that the United States was seeking biological samples for research and commercial purposes but was unwilling to guarantee the benefits from future vaccines.
"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for continued negotiations to secure a agreement acceptable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Background
This rejection follows a similar case in neighbouring Kenya, where a high court suspended a related deal with the US after concerns were filed about the safety of Kenyans' health data.
After returning to office recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and responsibility.
Based on statements, Sixteen African countries have to date signed these new agreements, constituting over $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment through US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no corresponding assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," he stated.
"Effectively, our nation would provide the basic resources for medical research without any assurance that the final treatments would be available to our people should a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending structures already established via the international organization.
Mangwana cited its Pandemic Benefit-Sharing system designed to manage potential pandemics.
"This mechanism is designed to ensure that when a country contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome continued discussions with our American counterparts on how future co-operation might be structured in a way that honours the independence and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but recommended that talks should continue considering much of the nation's HIV programmes depended on international support.
"In cases where specific concerns exist, including those relating to data governance or agreement terms, these can often be resolved through technical clarification and negotiated safeguards," the group added.
The situation underscores the ongoing challenges between receiving vital international aid and protecting local interests in an ever more data-driven world.